Welcome Guest | Register / Login

Biotechnology in Europe

Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players in the market?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. Have there been any new product launches in recent years?
7.5. What has been the rationale behind recent strategic partnerships?
7.6. Are there any threats to leading players?
8 Company Profiles
8.1. Merck & Co., Inc.
8.2. Boehringer Ingelheim GmbH
8.3. AstraZeneca PLC
8.4. F. Hoffmann-La Roche Ltd
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List of Tables
Table 1: Europe biotechnology industry value: $ million, 2014-18
Table 2: Europe biotechnology industry category segmentation: $ million, 2018
Table 3: Europe biotechnology industry geography segmentation: $ million, 2018
Table 4: Europe biotechnology industry value forecast: $ million, 2018-23
Table 5: Merck & Co., Inc.: key facts
Table 6: Merck & Co., Inc.: Annual Financial Ratios
Table 7: Merck & Co., Inc.: Key Employees
Table 8: Merck & Co., Inc.: Key Employees Continued
Table 9: Boehringer Ingelheim GmbH: key facts
Table 10: Boehringer Ingelheim GmbH: Key Employees
Table 11: AstraZeneca PLC: key facts
Table 12: AstraZeneca PLC: Annual Financial Ratios
Table 13: AstraZeneca PLC: Key Employees
Table 14: F. Hoffmann-La Roche Ltd: key facts
Table 15: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 16: F. Hoffmann-La Roche Ltd: Key Employees
Table 17: Europe size of population (million), 2014-18
Table 18: Europe gdp (constant 2005 prices, $ billion), 2014-18
Table 19: Europe gdp (current prices, $ billion), 2014-18
Table 20: Europe inflation, 2014-18
Table 21: Europe consumer price index (absolute), 2014-18
Table 22: Europe exchange rate, 2014-18

List of Figures
Figure 1: Europe biotechnology industry value: $ million, 2014-18
Figure 2: Europe biotechnology industry category segmentation: % share, by value, 2018
Figure 3: Europe biotechnology industry geography segmentation: % share, by value, 2018
Figure 4: Europe biotechnology industry value forecast: $ million, 2018-23
Figure 5: Forces driving competition in the biotechnology industry in Europe, 2018
Figure 6: Drivers of buyer power in the biotechnology industry in Europe, 2018
Figure 7: Drivers of supplier power in the biotechnology industry in Europe, 2018
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Europe, 2018
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Europe, 2018
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Europe, 2018
Single User License: Report will be emailed in PDF format and can be accessed by a specific user. This License type does not allow the report to be Printed.
Corporate User License: Report will be emailed in PDF format and allows all employees within the organization to access it. This License type allows the report to be Printed.
Why http://www.marketreportsonline.com/
Published By :MarketLine
Price
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy